Corporate Leadership
Mr. Richard Y. Lee, Ph.D.
Chairman, President and CEO
In 1993, Dr. Li Ya founded Amsino Medical Group in California, USA, and currently serves as the Group's Chairman and Chief Executive Officer.
Richard graduated from Peking University with a bachelor's degree in Economics in 1985. In the same year, he pursued further studies in the United States. Under the supervision of Professor Vernon Smith, the recipient of the 2002 Nobel Memorial Prize in Economic Sciences, he earned his Doctor of Economics degree from the University of Arizona in 1992. Prior to establishing Amsino Medical Group, Richard worked as an Assistant Professor of Economics at Gettysburg College in Pennsylvania, USA.
Richard has over 30 years of experience in the global medical device industry. His areas of expertise include general corporate management, strategic planning and execution, corporate development, mergers and acquisitions, research and development, global manufacturing, global strategic partnership, quality management systems, regulatory affairs, global sales and marketing, public relations and governmental affairs.
Under his leadership, Amsino has grown from a start-up to a global medical device company dedicated to advancing healthcare worldwide. The company operates multiple FDA registered R&D, manufacturing and distribution facilities strategically located in the US and in Asia, Amsino products are distributed in North America and in more than 100 other countries in LATAM, EMEA, and APAC.
As an Honorary Chairman of the China CEO Association, Richard is recognized as one of the most influential Chinese-American business leaders. He is also a Founder and Director of the United Beijing Association of America, Chairman of the Board of Directors of the Peking University Alumni Association, and a Director of the International Foundation for Experimental Economics in the United States. For 15 consecutive years, he has been a sponsor of Direct Relief International, supporting charitable development programs in numerous developing countries.
Mr. Peter Sun
Chief Financial Officer
Peter joined Amsino in January 2008 as the Chief Financial Officer based in Shanghai China. He received his MBA in Finance from the State University of New York at Albany.
Peter started his career in banking industry with U.S. Bancorp and later as project manager with Hewlett-Packard Company.
Peter also spent 5 years with Avanex Corporation (NASDAQ: AVNX), a Tier 1 developer and manufacturer of optical components, modules and sub-systems based in CA, as the Director of Finance and assisted the Company’s successful IPO on NASDAQ in 2001.
Prior to joining Amsino, Peter spent 4 years with Arasor International Limited (ASX: ARR), an advanced developer and manufacturer of optical laser modules based in CA, as the CFO and assisted the Company’s successful IPO on Australian Stock Exchange (ASX) in 2006.
Mr. Chester Chai
Sr. VP BD & Legal Affaires
Chester Chai returned to Amsino in 2018 as SVP of Global Marketing, Business Development and Assistant to the CEO. He comes to Amsino with over 28 years of medical device industry with experience working with companies such as Baxter, Hospira, and DeRoyal in both China and the United States. His extensive background includes business development, strategic planning, finance, marketing, supply chain management, product development, and venture capital investment.
Chester previously held the position of Corporate VP for Amsino from 2009 to 2012. He then moved to DeRoyal as the General Manager of Greater China and later established and managed a sourcing company, before returning to Amsino in 2018.
Chester has earned his M.B.A. degree from Kellogg School of Management at the University of Northwestern and an M.S. degree in Accounting from the University of Colorado Boulder. He has received his C.P.A. and also holds a B.S. degree in Mechanical Engineering from Shanghai Jiaotong University.
Mr. Frank Ling
Chief Operating Officer
Frank responsibles for managing Amsino manufacturing facilities in China and Canada (MedXL Inc.), as well as the Group’s Supply Chain, Global Strategic Sourcing and Operation Center. He joined Amsino in July 2012 as General Manager of Amsino Medical (Shanghai) Co., Ltd. From November 2017 to February 2019, he held the position of Vice President of Operations, Asia Pacific. He was promoted to Senior Vice President of Operations, Asia Pacific in March 2019, and further elevated to Chief Operating Officer (COO) in June 2023.
Frank received his Bachelor’s degree in Material Science from Shanghai Jiao Tong University in 1988.
Prior to joining Amsino, Frank took different management responsibilities in several multinational corporations, mainly focusing on manufacturing operations and technological development, with broad business backgrounds in medical device, machinery manufacturing and semiconductor industries.
Ms. Jane Gao
Senior VP of R&D and Commercialization--Medical Device
As Senior Vice President of R&D and Commercialization (Medical Devices), Jane leads the Medical Devices function and oversees the management, development and commercialization of product portfolios covering infusion therapy, enteral nutrition, urology and respiratory care.
Jane joined Amsino in April 2001 as a Product Manager. She was promoted to Project Development Department Manager since 2003 for all the new projects development. Jane was relocated to Amsino Medical (Shanghai) Co., Ltd as Deputy General Manager since November of 2005 until September of 2007. Jane was transferred to Amsino JD plant during September of 2007 to June of 2011 as General Manger.As of 2012, Jane has assumed the VP of R&D role. Promoted to Senior Vice President, R&D and Commercialization in February 2026.
Jane holds a Bachelor in Engineering from Jiangxi University of Science and Technology, with an emphasis in Mining Process Engineering.
Prior to joining Amsino, Jane worked for another Linhwa, a medical device company, for more than 4 years. She served as a product & mould technician, assistant to GM and international sales.
Mr. Paul Shen
Vice President of Quality Assurance
Paul Shen joined Amsino in 2001 as a Quality Manager, and was promoted to Vice President of QA in October, 2018. During his tenure at Amsino, Paul has served as Quality Manager, Deputy General Manager of Amsino Medical (Kunshan) Co., Ltd., Deputy General Manager of Amsino Medical (Shanghai) Co., Ltd, QC Director, and General Manager of Amsino Medical (Kunshan) Co., Ltd.
Paul received his Bachelor’s degree in microbiology from Fudan University, China.
Prior to joining Amsino, Paul Shen worked in Johnson & Johnson pharmaceutical company as a microbiologist and worked in Wyeth Nutritional company as a QA Supervisor.